​

MiNK Therapeutics (INKT) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

MiNK Therapeutics Revenue Highlights

00

MiNK Therapeutics Revenue by Period

MiNK Therapeutics Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31--100.00%
2022-12-31$2.70B100.00%
2021-12-31-100.00%
2020-12-31--100.00%
2019-12-31$689.63K-

MiNK Therapeutics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

MiNK Therapeutics Revenue by Quarter

DateRevenueChange
2025-09-30-100.00%
2025-06-30-100.00%
2025-03-31--100.00%
2024-12-31$3.77B100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$-11.71B100.00%
2023-09-30-100.00%
2023-06-30--100.00%
2023-03-31$11.71B332.88%
2022-12-31$2.70B73.07%
2022-09-30$1.56B0.22%
2022-06-30$1.56B100.00%
2022-03-31--100.00%
2021-12-31$221.92M100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31--

MiNK Therapeutics generated - in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

MiNK Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
OTLKOutlook Therapeutics$1.41T-
EQEquillium$41.09M-
SPRBSpruce Biosciences$4.91M-
HOWLWerewolf Therapeutics$1.89M-
VTVTvTv Therapeutics$1.02M-
OSTXOS Therapies--
INKTMiNK Therapeutics--
CRVOCervoMed--
IOBTIO Biotech--
NRXPNRx Pharmaceuticals-$242.00K
GANXGain Therapeutics--

INKT Revenue FAQ

What is MiNK Therapeutics’s yearly revenue?

MiNK Therapeutics's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. INKT's yearly revenue for 2022 was $2.7B, representing an increase of 100.00% compared to 2021.

What is MiNK Therapeutics’s quarterly revenue?

MiNK Therapeutics's quarterly revenue for Q3 2025 was $0, a 100.00% increase from the previous quarter (Q2 2025), and a 0% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). INKT's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024).

What is MiNK Therapeutics’s revenue growth rate?

MiNK Therapeutics's revenue growth rate for the last 3 years (2022-2024) was -100.00%, and for the last 5 years (2020-2024) was 0%.